CLDX
Celldex Therapeutics (CLDX) Investor Questions
Review Celldex Therapeutics (CLDX) faq with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Company
- Celldex Therapeutics
- Sector
- Healthcare
- Industry
- Biotechnology
- Overall BTI score
- 53
- Annual revenue
- $1.55M
- Annual net income
- $-258.76M
- Annual free cash flow
- $-213.66M
Celldex Therapeutics (CLDX) Investor Questions research
Celldex Therapeutics trades under the ticker CLDX. The company is classified in the Healthcare sector and the Biotechnology industry.
Investors commonly review CLDX through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.